Shandong Xinhua Pharmaceutical Switches Hong Kong Share Registrar
Company Announcements

Shandong Xinhua Pharmaceutical Switches Hong Kong Share Registrar

Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719) has released an update.

Shandong Xinhua Pharmaceutical Company Limited has announced a change in its branch share registrar and transfer office in Hong Kong, effective December 1, 2024. The new registrar will be Computershare Hong Kong Investor Services Limited, where all future share transfer applications should be lodged. This move is part of the company’s ongoing efforts to streamline its operations and enhance shareholder services.

For further insights into HK:0719 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskShandong Xinhua Pharma Secures Key Drug Approval
TipRanks HongKong Auto-Generated NewsdeskShandong Xinhua’s Generic Drug Receives Key Approval
TipRanks HongKong Auto-Generated NewsdeskShandong Xinhua Pharmaceutical Gains Approval for Pentazocine
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App